Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
Allergen (AGN) soared to $166.20 today, or 24% on reports that hedge fund manager Bill Ackman and Valeant Pharmaceuticals have bought a massive amount of stock in a bid to gain control of the company. Allergen, which makes the hit drug Botox, could be the target of the largest takeover of 2014. Analysts urged caution earlier in the day saying that the price had moved too quickly in a short period of time.
AGN data by YCharts
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
